View source for Protection Account along with Adverse Era of Unique Interest pertaining to Fruquintinib throughout China Patients with Previously Treated Metastatic Intestinal tract Cancer malignancy Research Phase Three or more FRESCO Tryout
From EECH Central
You do not have permission to edit this page, for the following reasons:
You can view and copy the source of this page.